secwatch.observer — SEC 8-K summary
======================================

Issuer:     Keros Therapeutics, Inc. (KROS)
CIK:        0001664710
Form:       8-K
Filed at:   2024-08-07T23:59:59+00:00
Accession:  0001664710-24-000069
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Keros updates corporate deck; no material facts discernible from truncated exhibit
--------------------------------------------------------------------------------

- Keros Therapeutics furnished an updated corporate presentation for investor meetings under Item 7.01.
- The attached Exhibit 99.1 text is incomplete in the filing, preventing extraction of specific updates.
- No financial results, clinical milestones, or guidance changes can be confirmed from available text.
- The filing is a routine practice and does not indicate any material new development.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1664710/000166471024000069/0001664710-24-000069-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1664710/000166471024000069/kros-20240807.htm
  HTML page:      https://secwatch.observer/filing/0001664710-24-000069

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer